Strides Pharma Science Ltd Analyst Rating
based on 4 analysts
75.00%
Buy
0.00%
Hold
25.00%
Sell
Based on 4 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1700.75
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Share analysis
Strides Pharma Science Ltd price forecast by 4 analysts
Upside of13.06%
High
₹1954
Target
₹1700.75
Low
₹1175
Strides Pharma Science Ltd target price ₹1700.75, a slight upside of 13.06% compared to current price of ₹1504.25. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2026:27.04%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Performance
Day's Low
Day's High
₹1,487.2₹1,54052 Week's Low
52 Week's High
₹482₹1,675
| Returns % | |
| 1 Month Return | -3.59 % |
| 3 Month Return | + 15.35 % |
| 1 Year Return | + 203.74 % |
| Market Stats | |
| Previous Close | ₹1,503.65 |
| Open | ₹1,503.00 |
| Volume | 1.94L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹13,827.30Cr |
Strides Pharma Science Ltd Key Statistics
| P/E Ratio | 59.72 |
| PEG Ratio | 1.18 |
| Market Cap | ₹13,827.30 Cr |
| P/B Ratio | 2.02 |
| EPS | -10.26 |
| Dividend Yield | 0.32 |
| Sector | Pharmaceuticals |
| ROE | 1.87 |
Strides Pharma Science Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹13,827.30 Cr | 54.25% | 0.66 | -₹95 Cr | ₹4,051 Cr | |
| NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
| NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
| NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
Strides Pharma Science Ltd Mutual Fund Holdings
About Strides Pharma Science Ltd
Share Price: ₹1504.25 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹13,827.30Cr as of today
Revenue: ₹1,201.11Cr as on September 2024 (Q3 24)
Net Profit: ₹93.66Cr as on September 2024 (Q3 24)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
| Organisation | Strides Pharma Science Ltd |
| Headquarters | Bangaluru |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Strides Pharma Science Ltd
Strides Pharma Reports Strong Profit Growth - 23 Nov, 2024
Strides Pharma Science Ltd's market capitalization stands at Rs 13,876 crore, with shares closing at Rs 1,509, up 0.39%. The company reported a significant increase in consolidated net profit from Rs 19 crores in Q2FY23 to Rs 94 crores in Q2FY25, reflecting a 70% CAGR over three years.
Strides Pharma Surges on OneSource Approval News - 21 Nov, 2024
Strides Pharma shares rose significantly after the NCLT approved the creation of OneSource Specialty Pharma, integrating specialized businesses and securing substantial investment. The stock is set for robust growth.
Strides Pharma Launches OneSource CDMO with NCLT Approval - 20 Nov, 2024
Strides Pharma Science Ltd has received NCLT approval to create OneSource, India's first specialty pharma CDMO, backed by Rs 801 crore investment. OneSource will list on BSE and NSE, with shareholders receiving shares in a 1:2 ratio.
Strides Pharma Receives NCLT Approval for OneSource - 19 Nov, 2024
Strides Pharma has received NCLT approval for OneSource, India's first specialty pharma CDMO, backed by Rs 801 crore investment. OneSource aims for robust growth and is expected to list on stock exchanges by FY25.
Strides Pharma to Consolidate European Operations - 29 Oct, 2024
Strides Pharma Science Limited's subsidiary is acquiring the remaining 30% stake in Strides Switzerland for CHF 1.01 million to strengthen its European market presence. This strategic move aims to enhance operational efficiency and financial performance. Strides has shown impressive growth, with multibagger returns of over 200% in one year.
Strides Pharma Reports Strong Growth and Strategic Acquisitions - 25 Oct, 2024
Strides Pharma Science Ltd reported strong financial results for September 2024, with significant YoY growth in sales and profits. The company maintains ambitious revenue targets for the US market while acquiring the remaining stake in Strides Switzerland to strengthen its European presence.
Insights on Strides Pharma Science Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 18.18 Cr → 93.23 Cr (in ₹), with an average increase of 49.4% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.50% to 10.80% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.07K Cr → 1.22K Cr (in ₹), with an average increase of 6.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, STAR stock has moved up by 10.1%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 26.71% to 30.08% in Sep 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 25.86% to 25.84% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 28.87% to 25.83% in Sep 2024 quarter
Strides Pharma Science Ltd Financials
Index Inclusions
Strides Pharma Science Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 25.84% | ||
| Foreign Institutions | 30.08% | 12.63 | |
| Mutual Funds | 10.8% | 2.83 | |
| Retail Investors | 25.83% | ||
| Others | 7.45% |
Strides Pharma Science Ltd Key Indicators
Strides Pharma Science Ltd Valuation
Strides Pharma Science Ltd in the last 5 years
Lowest (-179.24x)
July 5, 2021
Industry (54.77x)
November 22, 2024
Today (59.72x)
November 22, 2024
Highest (2764.02x)
September 27, 2024
Strides Pharma Science Ltd Earnings and Dividends
Strides Pharma Science Ltd Earnings Results
Strides Pharma Science Ltd’s net profit jumped 170.98% since last year same period to ₹93.23Cr in the Q2 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 32.81% jump in its net profits since last 3-months.
Read More about Earnings ResultsStrides Pharma Science Ltd Dividends May,2024
In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.27%.
Read More about Dividends
Strides Pharma Science Ltd Technicals Summary
Bearish
Neutral
Bullish
Strides Pharma Science Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Strides Pharma Science Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Strides Pharma Science Ltd shares.
Strides Pharma Science Ltd (STAR) share price today is ₹1504.25
Strides Pharma Science Ltd is listed on NSE
Strides Pharma Science Ltd is listed on BSE
- Today’s highest price of Strides Pharma Science Ltd is ₹1540.
- Today’s lowest price of Strides Pharma Science Ltd is ₹1487.2.
PE Ratio of Strides Pharma Science Ltd is 59.72
PE ratio = Strides Pharma Science Ltd Market price per share / Strides Pharma Science Ltd Earnings per share
Today’s traded volume of Strides Pharma Science Ltd(STAR) is 1.94L.
Today’s market capitalisation of Strides Pharma Science Ltd(STAR) is ₹13827.3Cr.
| Strides Pharma Science Ltd(STAR | Price |
|---|---|
52 Week High | ₹1675 |
52 Week Low | ₹482 |
Strides Pharma Science Ltd(STAR) share price is ₹1504.25. It is down -10.19% from its 52 Week High price of ₹1675
Strides Pharma Science Ltd(STAR) share price is ₹1504.25. It is up 212.09% from its 52 Week Low price of ₹482
| Strides Pharma Science Ltd(STAR | Returns |
|---|---|
1 Day Returns | 0.6% |
1 Month Returns | -3.59% |
3 Month Returns | 15.35% |
1 Year Returns | 203.74% |